clinical trial · NCT06842121
A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
Parenteral NutritionSodium Glycerophosphate InjectionSodium Phosphates Injection
brief summary
This is a phase 1, prospective, single-center, randomized sequence, double-blind, 2-way crossover, relative bioavailability study in healthy adult subjects comparing Sodium Glycerophosphate Injection (SGP) to Sodium Phosphate Injection (NaP). In this study it is planned to randomize approximately 42 healthy male and female subjects. All study periods will be completed during a single residency, the overall duration of residency will be 11 days (10 nights).
started
Jan 27, 2025
primary completion
May 22, 2025
completion
May 22, 2025
last updated
Jun 29, 2025
official title
Phase 1, Prospective, Single-Center, Randomized Sequence, Double-Blind, 2-Way Crossover Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol